n-methylpyrrolidone has been researched along with triacetin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodbeck, KJ; DesNoyer, JR; McHugh, AJ | 1 |
| Liu, H; Venkatraman, SS | 1 |
| Boudier, A; Dupuis, F; Lartaud, I; Leroy, P; Maincent, P; Nouvel, C; Parent, M; Sapin, A; Six, JL | 1 |
| Ahmed, TA; Hussain, MD; Ibrahim, HM; Kaseem, A; Nutan, MT; Samy, AM | 1 |
| Jensen, H; Larsen, SW; Petersen, NJ; Sun, Y; Østergaard, J | 1 |
5 other study(ies) available for n-methylpyrrolidone and triacetin
| Article | Year |
|---|---|
Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer.
Topics: Absorption; Benzoates; Biocompatible Materials; Chemical Precipitation; Diffusion; Drug Delivery Systems; Gels; Lactic Acid; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Proteins; Pyrrolidinones; Solubility; Solutions; Solvents; Thermodynamics; Time Factors; Triacetin | 1999 |
Cosolvent effects on the drug release and depot swelling in injectable in situ depot-forming systems.
Topics: Delayed-Action Preparations; Dimethyl Sulfoxide; Drug Delivery Systems; Hydrogen-Ion Concentration; Kinetics; Pyrrolidinones; Solvents; Triacetin | 2012 |
Are in situ formulations the keys for the therapeutic future of S-nitrosothiols?
Topics: Animals; Arterial Pressure; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Implants; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Telemetry; Triacetin; Vasodilation; Vasodilator Agents | 2013 |
Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.
Topics: Absorbable Implants; Acetates; Animals; Chemistry, Pharmaceutical; Cyclopropanes; Dimethyl Sulfoxide; Drug Implants; Drug Stability; Injections, Intramuscular; Lactic Acid; Leukotriene Antagonists; Male; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Quinolines; Rats, Sprague-Dawley; Solubility; Solvents; Sulfides; Technology, Pharmaceutical; Temperature; Triacetin | 2014 |
Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
Topics: Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Implants; Drug Liberation; Hydrogels; Lactalbumin; Lactic Acid; Piroxicam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Spectrophotometry, Ultraviolet; Spectrum Analysis; Subcutaneous Tissue; Triacetin | 2018 |